Genetic Epidemiology of Lymphoproliferative Disorders
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Monoclonal B-Cell Lymphocytosis, Multiple Myeloma
Both
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Monoclonal B-Cell Lymphocytosis, Multiple Myeloma
Trial Information
Genetic Epidemiology of Lymphoproliferative Disorders
Inclusion Criteria
At least 2 living, blood related relatives, affected with a lymphoproliferative disorder.
Type of Study:
Observational
Study Design:
Observational Model: Family-Based, Time Perspective: Prospective
Outcome Measure:
Risk of blood or lymphoma
Outcome Time Frame:
Ongoing
Safety Issue:
No
Principal Investigator
Susan Slager, Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Mayo Clinic
Authority:
United States: Institutional Review Board
Study ID:
489-04
NCT ID:
NCT00626496
Start Date:
April 2004
Completion Date:
Related Keywords:
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, B-Cell
- Monoclonal B-Cell Lymphocytosis
- Multiple Myeloma
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lymphocytosis
- Lymphoma
- Lymphoma, Non-Hodgkin
- Lymphoproliferative Disorders
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Lymphoma, B-Cell
Name | Location |
|---|---|
| Mayo Clinic | Rochester, Minnesota 55905 |
